Industry Research Reports
Global Transdermal Drug Patches Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 101 Pages
Report ld: 3466451
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Transdermal Drug Patches Market Size(US$)
CAGR 2025-2031
1.9%
Market Size,2031
USD 7,900
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 7,073 million
Market Forecast in 2031(Value)
US$ 7,900 million
CAGR
1.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Transdermal Drug Patches was valued at US$ 6956 million in the year 2024 and is projected to reach a revised size of US$ 7900 million by 2031, growing at a CAGR of 1.9% during the forecast period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Patches.
The Transdermal Drug Patches market size, estimations, and forecasts are provided in terms of sales volume (M Pieces) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Drug Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Drug Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Transdermal Drug Patches Market Overview
1.1 Product Definition
1.2 Transdermal Drug Patches by Type
1.2.1 Global Transdermal Drug Patches Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Drug Patches by Application
1.3.1 Global Transdermal Drug Patches Market Value by Application (2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Patches Market Size Estimates and Forecasts
1.4.1 Global Transdermal Drug Patches Revenue 2020-2031
1.4.2 Global Transdermal Drug Patches Sales 2020-2031
1.4.3 Global Transdermal Drug Patches Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Drug Patches Market Competition by Manufacturers
2.1 Global Transdermal Drug Patches Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Drug Patches Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Drug Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Drug Patches, Product Type & Application
2.7 Global Key Manufacturers of Transdermal Drug Patches, Date of Enter into This Industry
2.8 Global Transdermal Drug Patches Market Competitive Situation and Trends
2.8.1 Global Transdermal Drug Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Drug Patches Players Market Share by Revenue
2.8.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Drug Patches Market Scenario by Region
3.1 Global Transdermal Drug Patches Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Drug Patches Sales by Region: 2020-2031
3.2.1 Global Transdermal Drug Patches Sales by Region: 2020-2025
3.2.2 Global Transdermal Drug Patches Sales by Region: 2026-2031
3.3 Global Transdermal Drug Patches Revenue by Region: 2020-2031
3.3.1 Global Transdermal Drug Patches Revenue by Region: 2020-2025
3.3.2 Global Transdermal Drug Patches Revenue by Region: 2026-2031
3.4 North America Transdermal Drug Patches Market Facts & Figures by Country
3.4.1 North America Transdermal Drug Patches Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Drug Patches Sales by Country (2020-2031)
3.4.3 North America Transdermal Drug Patches Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Drug Patches Market Facts & Figures by Country
3.5.1 Europe Transdermal Drug Patches Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Drug Patches Sales by Country (2020-2031)
3.5.3 Europe Transdermal Drug Patches Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Drug Patches Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Drug Patches Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Drug Patches Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Drug Patches Market Facts & Figures by Country
3.7.1 Latin America Transdermal Drug Patches Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Drug Patches Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Drug Patches Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Drug Patches Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Drug Patches Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Drug Patches Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Drug Patches Sales by Type (2020-2031)
4.1.1 Global Transdermal Drug Patches Sales by Type (2020-2025)
4.1.2 Global Transdermal Drug Patches Sales by Type (2026-2031)
4.1.3 Global Transdermal Drug Patches Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Drug Patches Revenue by Type (2020-2031)
4.2.1 Global Transdermal Drug Patches Revenue by Type (2020-2025)
4.2.2 Global Transdermal Drug Patches Revenue by Type (2026-2031)
4.2.3 Global Transdermal Drug Patches Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Drug Patches Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Drug Patches Sales by Application (2020-2031)
5.1.1 Global Transdermal Drug Patches Sales by Application (2020-2025)
5.1.2 Global Transdermal Drug Patches Sales by Application (2026-2031)
5.1.3 Global Transdermal Drug Patches Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Drug Patches Revenue by Application (2020-2031)
5.2.1 Global Transdermal Drug Patches Revenue by Application (2020-2025)
5.2.2 Global Transdermal Drug Patches Revenue by Application (2026-2031)
5.2.3 Global Transdermal Drug Patches Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Drug Patches Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Transdermal Drug Patches Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Company Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Transdermal Drug Patches Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Beijing Tide Pharmaceutical
6.7.1 Beijing Tide Pharmaceutical Company Information
6.7.2 Beijing Tide Pharmaceutical Description and Business Overview
6.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
6.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.8 Chattem
6.8.1 Chattem Company Information
6.8.2 Chattem Description and Business Overview
6.8.3 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chattem Transdermal Drug Patches Product Portfolio
6.8.5 Chattem Recent Developments/Updates
6.9 Nitto Denko
6.9.1 Nitto Denko Company Information
6.9.2 Nitto Denko Description and Business Overview
6.9.3 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nitto Denko Transdermal Drug Patches Product Portfolio
6.9.5 Nitto Denko Recent Developments/Updates
6.10 Grünenthal
6.10.1 Grünenthal Company Information
6.10.2 Grünenthal Description and Business Overview
6.10.3 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Grünenthal Transdermal Drug Patches Product Portfolio
6.10.5 Grünenthal Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Company Information
6.11.2 Mundipharma Description and Business Overview
6.11.3 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mundipharma Transdermal Drug Patches Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GSK Transdermal Drug Patches Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Luye Pharma Group
6.13.1 Luye Pharma Group Company Information
6.13.2 Luye Pharma Group Description and Business Overview
6.13.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
6.13.5 Luye Pharma Group Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Company Information
6.14.2 Bayer Description and Business Overview
6.14.3 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bayer Transdermal Drug Patches Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 IBSA Group
6.15.1 IBSA Group Company Information
6.15.2 IBSA Group Description and Business Overview
6.15.3 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IBSA Group Transdermal Drug Patches Product Portfolio
6.15.5 IBSA Group Recent Developments/Updates
6.16 Dr Reddy’s Laboratories
6.16.1 Dr Reddy’s Laboratories Company Information
6.16.2 Dr Reddy’s Laboratories Description and Business Overview
6.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
6.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Drug Patches Industry Chain Analysis
7.2 Transdermal Drug Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Drug Patches Production Mode & Process Analysis
7.4 Transdermal Drug Patches Sales and Marketing
7.4.1 Transdermal Drug Patches Sales Channels
7.4.2 Transdermal Drug Patches Distributors
7.5 Transdermal Drug Patches Customer Analysis
8 Transdermal Drug Patches Market Dynamics
8.1 Transdermal Drug Patches Industry Trends
8.2 Transdermal Drug Patches Market Drivers
8.3 Transdermal Drug Patches Market Challenges
8.4 Transdermal Drug Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Transdermal Drug Patches Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Transdermal Drug Patches Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Transdermal Drug Patches Market Competitive Situation by Manufacturers in 2024
Table 4. Global Transdermal Drug Patches Sales (M Pieces) of Key Manufacturers (2020-2025)
Table 5. Global Transdermal Drug Patches Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Transdermal Drug Patches Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Transdermal Drug Patches Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Transdermal Drug Patches Average Price (USD/Piece) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Transdermal Drug Patches, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transdermal Drug Patches, Product Type & Application
Table 12. Global Key Manufacturers of Transdermal Drug Patches, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Drug Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Transdermal Drug Patches Sales by Region (2020-2025) & (M Pieces)
Table 18. Global Transdermal Drug Patches Sales Market Share by Region (2020-2025)
Table 19. Global Transdermal Drug Patches Sales by Region (2026-2031) & (M Pieces)
Table 20. Global Transdermal Drug Patches Sales Market Share by Region (2026-2031)
Table 21. Global Transdermal Drug Patches Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Transdermal Drug Patches Revenue Market Share by Region (2020-2025)
Table 23. Global Transdermal Drug Patches Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Transdermal Drug Patches Revenue Market Share by Region (2026-2031)
Table 25. North America Transdermal Drug Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Transdermal Drug Patches Sales by Country (2020-2025) & (M Pieces)
Table 27. North America Transdermal Drug Patches Sales by Country (2026-2031) & (M Pieces)
Table 28. North America Transdermal Drug Patches Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Transdermal Drug Patches Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Transdermal Drug Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Transdermal Drug Patches Sales by Country (2020-2025) & (M Pieces)
Table 32. Europe Transdermal Drug Patches Sales by Country (2026-2031) & (M Pieces)
Table 33. Europe Transdermal Drug Patches Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Transdermal Drug Patches Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Transdermal Drug Patches Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Transdermal Drug Patches Sales by Region (2020-2025) & (M Pieces)
Table 37. Asia Pacific Transdermal Drug Patches Sales by Region (2026-2031) & (M Pieces)
Table 38. Asia Pacific Transdermal Drug Patches Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Transdermal Drug Patches Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transdermal Drug Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Transdermal Drug Patches Sales by Country (2020-2025) & (M Pieces)
Table 42. Latin America Transdermal Drug Patches Sales by Country (2026-2031) & (M Pieces)
Table 43. Latin America Transdermal Drug Patches Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Transdermal Drug Patches Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Transdermal Drug Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Transdermal Drug Patches Sales by Country (2020-2025) & (M Pieces)
Table 47. Middle East and Africa Transdermal Drug Patches Sales by Country (2026-2031) & (M Pieces)
Table 48. Middle East and Africa Transdermal Drug Patches Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Transdermal Drug Patches Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Transdermal Drug Patches Sales (M Pieces) by Type (2020-2025)
Table 51. Global Transdermal Drug Patches Sales (M Pieces) by Type (2026-2031)
Table 52. Global Transdermal Drug Patches Sales Market Share by Type (2020-2025)
Table 53. Global Transdermal Drug Patches Sales Market Share by Type (2026-2031)
Table 54. Global Transdermal Drug Patches Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Transdermal Drug Patches Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Transdermal Drug Patches Revenue Market Share by Type (2020-2025)
Table 57. Global Transdermal Drug Patches Revenue Market Share by Type (2026-2031)
Table 58. Global Transdermal Drug Patches Price (USD/Piece) by Type (2020-2025)
Table 59. Global Transdermal Drug Patches Price (USD/Piece) by Type (2026-2031)
Table 60. Global Transdermal Drug Patches Sales (M Pieces) by Application (2020-2025)
Table 61. Global Transdermal Drug Patches Sales (M Pieces) by Application (2026-2031)
Table 62. Global Transdermal Drug Patches Sales Market Share by Application (2020-2025)
Table 63. Global Transdermal Drug Patches Sales Market Share by Application (2026-2031)
Table 64. Global Transdermal Drug Patches Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Transdermal Drug Patches Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Transdermal Drug Patches Revenue Market Share by Application (2020-2025)
Table 67. Global Transdermal Drug Patches Revenue Market Share by Application (2026-2031)
Table 68. Global Transdermal Drug Patches Price (USD/Piece) by Application (2020-2025)
Table 69. Global Transdermal Drug Patches Price (USD/Piece) by Application (2026-2031)
Table 70. Hisamitsu Pharmaceutical Company Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 73. Hisamitsu Pharmaceutical Transdermal Drug Patches Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Transdermal Drug Patches Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 83. Mylan Transdermal Drug Patches Product
Table 84. Mylan Recent Developments/Updates
Table 85. UCB Pharma Company Information
Table 86. UCB Pharma Description and Business Overview
Table 87. UCB Pharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 88. UCB Pharma Transdermal Drug Patches Product
Table 89. UCB Pharma Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 93. Novartis Transdermal Drug Patches Product
Table 94. Novartis Recent Developments/Updates
Table 95. Teva Pharmaceutical Company Information
Table 96. Teva Pharmaceutical Description and Business Overview
Table 97. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Transdermal Drug Patches Product
Table 99. Teva Pharmaceutical Recent Developments/Updates
Table 100. Beijing Tide Pharmaceutical Company Information
Table 101. Beijing Tide Pharmaceutical Description and Business Overview
Table 102. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 103. Beijing Tide Pharmaceutical Transdermal Drug Patches Product
Table 104. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 105. Chattem Company Information
Table 106. Chattem Description and Business Overview
Table 107. Chattem Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 108. Chattem Transdermal Drug Patches Product
Table 109. Chattem Recent Developments/Updates
Table 110. Nitto Denko Company Information
Table 111. Nitto Denko Description and Business Overview
Table 112. Nitto Denko Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 113. Nitto Denko Transdermal Drug Patches Product
Table 114. Nitto Denko Recent Developments/Updates
Table 115. Grünenthal Company Information
Table 116. Grünenthal Description and Business Overview
Table 117. Grünenthal Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 118. Grünenthal Transdermal Drug Patches Product
Table 119. Grünenthal Recent Developments/Updates
Table 120. Mundipharma Company Information
Table 121. Mundipharma Description and Business Overview
Table 122. Mundipharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 123. Mundipharma Transdermal Drug Patches Product
Table 124. Mundipharma Recent Developments/Updates
Table 125. GSK Company Information
Table 126. GSK Description and Business Overview
Table 127. GSK Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 128. GSK Transdermal Drug Patches Product
Table 129. GSK Recent Developments/Updates
Table 130. Luye Pharma Group Company Information
Table 131. Luye Pharma Group Description and Business Overview
Table 132. Luye Pharma Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 133. Luye Pharma Group Transdermal Drug Patches Product
Table 134. Luye Pharma Group Recent Developments/Updates
Table 135. Bayer Company Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 138. Bayer Transdermal Drug Patches Product
Table 139. Bayer Recent Developments/Updates
Table 140. IBSA Group Company Information
Table 141. IBSA Group Description and Business Overview
Table 142. IBSA Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 143. IBSA Group Transdermal Drug Patches Product
Table 144. IBSA Group Recent Developments/Updates
Table 145. Dr Reddy’s Laboratories Company Information
Table 146. Dr Reddy’s Laboratories Description and Business Overview
Table 147. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2020-2025)
Table 148. Dr Reddy’s Laboratories Transdermal Drug Patches Product
Table 149. Dr Reddy’s Laboratories Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Transdermal Drug Patches Distributors List
Table 153. Transdermal Drug Patches Customers List
Table 154. Transdermal Drug Patches Market Trends
Table 155. Transdermal Drug Patches Market Drivers
Table 156. Transdermal Drug Patches Market Challenges
Table 157. Transdermal Drug Patches Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Transdermal Drug Patches
Figure 2. Global Transdermal Drug Patches Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transdermal Drug Patches Market Share by Type: 2024 & 2031
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Rivastigmine Transdermal Patch Product Picture
Figure 6. Fentanyl Transdermal Patch Product Picture
Figure 7. Lidocaine Patch Product Picture
Figure 8. Diclofenac Patch Product Picture
Figure 9. Nicotine Transdermal Patch Product Picture
Figure 10. Others Product Picture
Figure 11. Global Transdermal Drug Patches Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Transdermal Drug Patches Market Share by Application: 2024 & 2031
Figure 13. Rx Channel
Figure 14. OTC Channel
Figure 15. Global Transdermal Drug Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transdermal Drug Patches Market Size (2020-2031) & (US$ Million)
Figure 17. Global Transdermal Drug Patches Sales (2020-2031) & (M Pieces)
Figure 18. Global Transdermal Drug Patches Average Price (USD/Piece) & (2020-2031)
Figure 19. Transdermal Drug Patches Report Years Considered
Figure 20. Transdermal Drug Patches Sales Share by Manufacturers in 2024
Figure 21. Global Transdermal Drug Patches Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Transdermal Drug Patches Players: Market Share by Revenue in Transdermal Drug Patches in 2024
Figure 23. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Transdermal Drug Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Transdermal Drug Patches Sales Market Share by Country (2020-2031)
Figure 26. North America Transdermal Drug Patches Revenue Market Share by Country (2020-2031)
Figure 27. United States Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Transdermal Drug Patches Sales Market Share by Country (2020-2031)
Figure 30. Europe Transdermal Drug Patches Revenue Market Share by Country (2020-2031)
Figure 31. Germany Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Transdermal Drug Patches Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region (2020-2031)
Figure 38. China Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Transdermal Drug Patches Sales Market Share by Country (2020-2031)
Figure 48. Latin America Transdermal Drug Patches Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Transdermal Drug Patches Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Transdermal Drug Patches by Type (2020-2031)
Figure 58. Global Revenue Market Share of Transdermal Drug Patches by Type (2020-2031)
Figure 59. Global Transdermal Drug Patches Price (USD/Piece) by Type (2020-2031)
Figure 60. Global Sales Market Share of Transdermal Drug Patches by Application (2020-2031)
Figure 61. Global Revenue Market Share of Transdermal Drug Patches by Application (2020-2031)
Figure 62. Global Transdermal Drug Patches Price (USD/Piece) by Application (2020-2031)
Figure 63. Transdermal Drug Patches Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Transdermal Drug Patches market size from 2025 to 2031?
The annual compound growth rate of the global Transdermal Drug Patches market is 1.9% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Transdermal Drug Patches in 2031?
Which companies rank high in the global Transdermal Drug Patches market?
What was the global market size of Transdermal Drug Patches in 2025?
Related Reports
Global Transdermal Drug Patches Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Transdermal Drug Patches market is projected to grow from US$ 3520 million in 2025 to US$ 4088 million by 2032, at a CAGR of 2.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-28
Pages: 170
USD 4900.00
(Single User License)
Global Transdermal Drug Patches Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transdermal Drug Patches market size was US$ 3520 million in 2025 and is forecast to reach a readjusted size of US$ 4088 million by 2032 with a CAGR of 2.3% during the forecast period 2026-2032.
Published Date: 2026-04-28
Pages: 138
USD 4250.00
(Single User License)
Global Transdermal Drug Patches Market Research Report 2026
The global Transdermal Drug Patches market was valued at US$ 3520 million in 2025 and is anticipated to reach US$ 4088 million by 2032, at a CAGR of 2.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 122
USD 2900.00
(Single User License)
Transdermal Drug Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transdermal Drug Patches was estimated to be worth US$ 3520 million in 2025 and is projected to reach US$ 4088 million, growing at a CAGR of 2.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 137
USD 3950.00
(Single User License)
Global Transdermal Drug Patches Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Transdermal Drug Patches market is projected to grow from US$ 6956 million in 2024 to US$ 7900 million by 2031, at a CAGR of 1.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 175
USD 4900.00
(Single User License)
Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Transdermal Drug Patches was estimated to be worth US$ 6956 million and is forecast to reach approximately US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 174
USD 5900.00
(Single User License)
Global Transdermal Drug Patches Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transdermal Drug Patches market size was US$ 6956 million in 2024 and is forecast to a readjusted size of US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 101
USD 4250.00
(Single User License)
Transdermal Drug Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transdermal Drug Patches was estimated to be worth US$ 6956 million in 2024 and is forecast to a readjusted size of US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 144
USD 3950.00
(Single User License)
Global Transdermal Drug Patches Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Published Date: 2024-04-16
Pages: 171
USD 5900.00
(Single User License)
Global Transdermal Drug Patches Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Transdermal Drug Patches market is projected to grow from US$ 3520 million in 2025 to US$ 4088 million by 2032, at a CAGR of 2.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-28
Pages: 170
USD 4900.00 (Single User License)Global Transdermal Drug Patches Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transdermal Drug Patches market size was US$ 3520 million in 2025 and is forecast to reach a readjusted size of US$ 4088 million by 2032 with a CAGR of 2.3% during the forecast period 2026-2032.
Published: 2026-04-28
Pages: 138
USD 4250.00 (Single User License)Global Transdermal Drug Patches Market Research Report 2026
The global Transdermal Drug Patches market was valued at US$ 3520 million in 2025 and is anticipated to reach US$ 4088 million by 2032, at a CAGR of 2.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 122
USD 2900.00 (Single User License)Transdermal Drug Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transdermal Drug Patches was estimated to be worth US$ 3520 million in 2025 and is projected to reach US$ 4088 million, growing at a CAGR of 2.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 137
USD 3950.00 (Single User License)Global Transdermal Drug Patches Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Transdermal Drug Patches market is projected to grow from US$ 6956 million in 2024 to US$ 7900 million by 2031, at a CAGR of 1.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 175
USD 4900.00 (Single User License)Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Transdermal Drug Patches was estimated to be worth US$ 6956 million and is forecast to reach approximately US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 174
USD 5900.00 (Single User License)Global Transdermal Drug Patches Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transdermal Drug Patches market size was US$ 6956 million in 2024 and is forecast to a readjusted size of US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 101
USD 4250.00 (Single User License)Transdermal Drug Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transdermal Drug Patches was estimated to be worth US$ 6956 million in 2024 and is forecast to a readjusted size of US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 144
USD 3950.00 (Single User License)Global Transdermal Drug Patches Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Published: 2024-04-17
Pages: 179
USD 5600.00 (Single User License)Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Published: 2024-04-16
Pages: 171
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now